M?ller Jensen C, Zargari Marandi R, Moestrup KS, Mourad A, Mena Lora AJ, Sherman BT, Vock DM, Nordwall JA, Carson JM, Peiffer-Smadja N, Aggarwal NR, Naiman NE, Brown SM, Barrett TW, Hatlen T, Kj?rgaard VS, Chang W, Sydes MR, Lundgren J, Jensen TO, STRIVE Network and ITAC and TICO Study Groups
Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials. JAMIA Open. 2026 Jun; 9(3):ooag079.
Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials.
Hatlen TJ, Shurtleff DB, Loeser JD, Ojemann JG, Avellino AM, Ellenbogen RG
Nonprogrammable and programmable cerebrospinal fluid shunt valves: a 5-year study. J Neurosurg Pediatr. 2012 May; 9(5):462-7.
Nonprogrammable and programmable cerebrospinal fluid shunt valves: a 5-year study.
Necrotic ulcer on the thigh. Cutis. 2017 Aug; 100(2):80;91.
High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose. AIDS Res Hum Retroviruses. 2018 05; 34(5):399-403.
High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose.
Hatlen TJ, Filler SG, Bayer A, Shah S, Shodhan S, Van TT
Aspergillus endocarditis diagnosed by fungemia plus serum antigen testing. Med Mycol Case Rep. 2019 Mar; 23:1-3.
Aspergillus endocarditis diagnosed by fungemia plus serum antigen testing.
Contributory factors to postoperative spinal fusion complications for children with myelomeningocele. Spine (Phila Pa 1976). 2010 Jun 01; 35(13):1294-9.
Contributory factors to postoperative spinal fusion complications for children with myelomeningocele.
Sunpath H, Hatlen TJ, Naidu KK, Msimango P, Adams RN, Moosa MS, Marconi VC, Murphy RA, Gandhi RT, Pillay S, Siedner M, Naidoo K
Targeting the third '90': introducing the viral load champion. Public Health Action. 2018 Dec 21; 8(4):225-231.
Targeting the third '90': introducing the viral load champion.
Hatlen TJ, Flor R, Nguyen MH, Lee GH, Miller LG
The Journal of antimicrobial chemotherapy
Oral fosfomycin use for pyelonephritis and complicated urinary tract infections: a 1 year review of outcomes and prescribing habits in a large municipal healthcare system. J Antimicrob Chemother. 2020 07 01; 75(7):1993-1997.
Oral fosfomycin use for pyelonephritis and complicated urinary tract infections: a 1 year review of outcomes and prescribing habits in a large municipal healthcare system.
Infectious disease clinics of North America
Staphylococcal Skin and Soft Tissue Infections. Infect Dis Clin North Am. 2021 03; 35(1):81-105.
Staphylococcal Skin and Soft Tissue Infections.
Patel J, Bass D, Beishuizen A, Bocca Ruiz X, Boughanmi H, Cahn A, Colombo H, Criner GJ, Davy K, de-Miguel-D?ez J, Doreski PA, Fernandes S, Fran?ois B, Gupta A, Hanrott K, Hatlen T, Inman D, Isaacs JD, Jarvis E, Kostina N, Kropotina T, Lacherade JC, Lakshminarayanan D, Martinez-Ayala P, McEvoy C, Meziani F, Monchi M, Mukherjee S, Mu?oz-Berm?dez R, Neisen J, O'Shea C, Plantefeve G, Schifano L, Schwab LE, Shahid Z, Shirano M, Smith JE, Sprinz E, Summers C, Terzi N, Tidswell MA, Trefilova Y, Williamson R, Wyncoll D, Layton M
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR). Eur Respir J. 2023 02; 61(2).
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR).
Hatlen T, Mroch H, Tuttle K, Ojogho O, Rooney M, Desmond S, Bani-Hani S
Disseminated Adenovirus Nephritis After Kidney Transplantation. Kidney Int Rep. 2018 Jan; 3(1):19-23.
Disseminated Adenovirus Nephritis After Kidney Transplantation.
Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER, ACTIV-3/TICO Study Group
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study. Lancet Microbe. 2024 06; 5(6):e559-e569.
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
Murphy RA, Bedesi PH, Perumal N, Gosnell BI, Hatlen TJ, Brijkumar J
Dolutegravir Resistance in African Programmatic Settings Among Patients With Failure of Dolutegravir-based ART. Open Forum Infect Dis. 2024 Jul; 11(7):ofae321.
Dolutegravir Resistance in African Programmatic Settings Among Patients With Failure of Dolutegravir-based ART.
Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup R?ge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. J Infect Dis. 2025 Mar 17; 231(3):677-683.
Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.
Advances in Treatment and Prevention of HIV. JAMA. 2025 Feb 18; 333(7):576-578.
Advances in Treatment and Prevention of HIV.
Marks KM, Kang M, Umbleja T, Cox A, Vigil KJ, Ta NT, Omoz-Oarhe A, Perazzo H, Kosgei J, Hatlen T, Price J, Katsidzira L, Supparatpinyo K, Knowles K, Alston-Smith BL, Rathod P, Sherman KE, ACTG 5379 (BEe-HIVe) Study Team
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial. JAMA. 2025 01 28; 333(4):295-306.
HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe-HIVe Randomized Clinical Trial.
S?bato S, Benet S, Rogers AJ, Murray TA, Skeans M, Mothe B, Paredes R, Mourad A, Kiweewa F, Kamel D, Jain MK, Lutaakome J, Nalubega MG, Sebudde N, Mylonakis E, Braun DL, Hatlen T, Kimuli I, Kitko C, Mugerwa H, Kitonsa J, Kim K, Tien PC, Highbarger J, McCormack AL, Sanchez A, Murray DD, Babiker AG, Davey VJ, Files DC, Gelijns AC, Higgs ES, Kan VL, Matthews GV, Pett SL, Lane HC, Reilly C, Goodman AL, Lundgren JD, Molt? J, ACTIV-3/VATICO study group and the STRIVE Network
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial). Sci Rep. 2025 Mar 22; 15(1):9882.
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial).
Sunpath H, Hatlen TJ, Moosa MS, Murphy RA, Siedner M, Naidoo K
Urgent need to improve programmatic management of patients with HIV failing first-line antiretroviral therapy. Public Health Action. 2020 Dec 21; 10(4):163-168.
Urgent need to improve programmatic management of patients with HIV failing first-line antiretroviral therapy.
Guzm?n JJ, Duffey MM, Weatherhead J, Clark EH, Herrick J, Amusu S, Chow FC, Allyn PR, Wald-Dickler N, Rodriguez JM, Bowman NM, Hatlen TJ, Martin D, Larsen T, Cervantes-Arslanian AM, Coyle C, White AC, Welford E, Cowell AN, Jenks JD, Henao-Martinez AF, Franco-Paredes C, Mathisen G, Lichtenberger P, Serpa JA, Bouzigard R, Castellino LM, O'Connell EM
Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USA. EClinicalMedicine. 2026 Apr; 94:103861.
Effect of different management strategies on outcomes in subarachnoid neurocysticercosis: a descriptive, multicentre, retrospective cohort study in the USA.
Sunpath H, Pillay S, Hatlen T, Murphy RA, Marconi VC, Moosa MS, Naidoo K, Siedner MJ
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation. S Afr Med J. 2021 Mar 31; 111(4):299-303.
A nurse-led intervention to improve management of virological failure in public sector HIV clinics in Durban, South Africa: A pre- and post-implementation evaluation.
ACTIV-3/TICO Study Group, Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM, Rogers R, Shehadeh F, Kaczynski M, Mylona EK, Syrigos KN, Rapti V, Lye DC, Hui DS, Leither L, Knowlton KU, Jain MK, Marines-Price R, Osuji A, Overcash JS, Kalomenidis I, Barmparessou Z, Waters M, Zepeda K, Chen P, Torbati S, Kiweewa F, Sebudde N, Almasri E, Hughes A, Bhagani SR, Rodger A, Sandkovsky U, Gottlieb RL, Nnakelu E, Trautner B, Menon V, Lutaakome J, Matthay M, Robinson P, Protopapas K, Koulouris N, Kimuli I, Baduashvili A, Braun DL, G?nthard HF, Ramachandruni S, Kidega R, Kim K, Hatlen TJ, Phillips AN, Murray DD, Jensen TO, Padilla ML, Accardi EX, Shaw-Saliba K, Dewar RL, Teitelbaum M, Natarajan V, Laverdure S, Highbarger HC, Rehman MT, Vogel S, Vall?e D, Crew P, Atri N, Schechner AJ, Pett S, Hudson F, Badrock J, Touloumi G, Brown SM, Self WH, North CM, Ginde AA, Chang CC, Kelleher A, Nagy-Agren S, Vasudeva S, Looney D, Nguyen HH, S?nchez A, Weintrob AC, Grund B, Sharma S, Reilly CS, Paredes R, Bednarska A, Gerry NP, Babiker AG, Davey VJ, Gelijns AC, Higgs ES, Kan V, Matthews G, Thompson BT, Legenne P, Chandra R, Lane HC, Neaton JD, Lundgren JD
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial. Ann Intern Med. 2022 09; 175(9):1266-1274.
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.
Mylonakis E, Lutaakome J, Jain MK, Rogers AJ, Molt? J, Benet S, Mourad A, Files DC, Mugerwa H, Kityo C, Kiweewa F, Nalubega MG, Kitonsa J, Nabenkema E, Murray DD, Braun D, Kamel D, Higgs ES, Hatlen TJ, Kan VL, Sanchez A, Tierney J, Denner E, Wentworth D, Babiker AG, Davey VJ, Gelijns AC, Matthews GV, Thompson BT, Lane HC, Neaton JD, Lundgren JD
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO). Med. 2022 08 12; 3(8):531-537.
Lessons from an international trial evaluating vaccination strategies for recovered inpatients with COVID-19 (VATICO).
Fetters KB, Judge SP, Daar ES, Hatlen TJ
Mayo Clinic proceedings. Innovations, quality & outcomes
Burden of Hyperglycemia in Patients Receiving Corticosteroids for Severe COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2022 Oct; 6(5):484-487.
Burden of Hyperglycemia in Patients Receiving Corticosteroids for Severe COVID-19.
Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, Gray GE, Grinsztejn B, Kotloff KL, Gay CL, Leav B, Miller J, Hirsch I, Sadoff J, Dunkle LM, Neuzil KM, Corey L, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, COVID-19 Prevention Network (CoVPN)
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. 2023 07 03; 6(7):e2323349.
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Jensen TO, Grandits GA, Jain MK, Murray TA, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens RA, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER, ACTIV-3/TICO Study Group
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19. J Infect Dis. 2024 03 14; 229(3):671-679.
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19.
Erlandson KM, McKhann A, Kitch DW, Palella FJ, Ellis RJ, Ances BM, Zanni MV, Diggs MR, Chu SM, Currier JS, Bloomfield GS, Malvestutto CD, Fichtenbaum CJ, Aberg JA, Koletar SL, Presti RM, Hatlen TJ, Skiest DJ, Douglas PS, Ribaudo HJ, Grinspoon SK
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV. AIDS. 2025 Nov 01; 39(13):1913-1919.
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV.
Munroe ES, Grandits GA, Hyzy RC, Prescott HC, Barrett TW, Dewar RL, Engen N, Goodman AL, Hatlen TJ, Highbarger H, Holland TL, Hughes G, Jensen TO, Khan MA, Kalomenidis I, Kang N, Laverdure S, Manian P, Menon V, Patel R, Ramachandruni S, Rehman T, Shaw-Saliba K, R?ge BT, Vock DM, Weintrob AC, Young BE, Frosch AP, STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. PLoS One. 2025; 20(6):e0325561.
Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
Charles R. Drew University of Medicine and Science